Thromboembolic disease
Conditions
Interventions
test group:None
Sponsors
Center for Clinical Pharmacology, the Third Xiangya Hospital, Central South University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) patients who will or are taking warfarin; (2) patients who can be followed up at least once; (3) Able to provide written informed consent, communicate well with researchers and complete the study in accordance with the research regulations.
Exclusion criteria
Exclusion criteria: (1) Medical records cannot be provided or are incomplete.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| international normalized ratio; | — |
Countries
China
Contacts
Public ContactLiming Liu
The Third Xiangya Hospital, Central South University
Outcome results
None listed